EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity

被引：4

作者：

Berg, Johannes Lorenz ^{[1
]}

Perfler, Bianca ^{[1
]}

Hatzl, Stefan ^{[1
]}

Uhl, Barbara ^{[1
]}

Reinisch, Andreas ^{[1
]}

Pregartner, Gudrun ^{[2
]}

Berghold, Andrea ^{[2
]}

Penz, Thomas ^{[3
]}

Schuster, Michael ^{[3
]}

Geissler, Klaus ^{[4
,5
]}

Prokesch, Andreas ^{[6
,7
,8
]}

Mueller-Tidow, Carsten ^{[9
]}

Hoefler, Gerald ^{[10
]}

Kashofer, Karl ^{[10
]}

Woelfler, Albert ^{[1
]}

Sill, Heinz ^{[1
]}

Caraffini, Veronica ^{[1
,11
]}

Zebisch, Armin ^{[1
,12
]}

机构：

[1] Med Univ Graz, Div Hematol, Graz, Austria

[2] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria

[3] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria

[4] Hosp Hietzing, Med Dept Hematol Oncol & Palliat Med 5, Vienna, Austria

[5] Sigmund Freud Univ, Vienna, Austria

[6] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Graz, Austria

[7] Med Univ Graz, Div Cell Biol Histol & Embryol, Graz, Austria

[8] BioTechMed Graz, Graz, Austria

[9] Univ Hosp Heidelberg, Heidelberg, Germany

[10] Med Univ Graz, Diagnost & Res Inst Pathol, Graz, Austria

[11] Univ Cambridge, MRC Canc Unit, Hutchison MRC Res Ctr, Cambridge, England

[12] Med Univ Graz, Div Pharmacol, Otto Loewi Res Ctr Vasc Biol Immunol & Inflammat, Graz, Austria

来源：

LEUKEMIA | 2021年 / 35卷 / 05期

基金：

奥地利科学基金会;

关键词：

D O I：

10.1038/s41375-021-01161-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1521 / 1526

页数：6

共 15 条

[11]

Smith Catherine C, 2013, Am Soc Clin Oncol Educ Book, P313, DOI 10.1200/EdBook_AM.2013.33.313

[12] Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles [J].

Subramanian, A ;

Tamayo, P ;

Mootha, VK ;

Mukherjee, S ;

Ebert, BL ;

Gillette, MA ;

Paulovich, A ;

Pomeroy, SL ;

Golub, TR ;

Lander, ES ;

Mesirov, JP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15545-15550

[13] Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras [J].

Wandler, Anica ;

Shannon, Kevin .

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (04)

[14] Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma [J].

Wang, Yanxiao ;

Hou, Ning ;

Cheng, Xuan ;

Zhang, Jishuai ;

Tan, Xiaohong ;

Zhang, Chong ;

Tang, Yuling ;

Teng, Yan ;

Yang, Xiao .

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (05) :652-659

[15] Signaling through RAS-RAF-MEK-ERK: from basics to bedside [J].

Zebisch, Armin ;

Czernilofsky, Armin P. ;

Keri, Gyoergy ;

Smigelskaite, Juja ;

Sill, Heinz ;

Troppmair, Jakob .

CURRENT MEDICINAL CHEMISTRY, 2007, 14 (05) :601-623

← 1 2 →